Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario R Ehlers

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Journal of Autoimmunity|April 13, 2016
Strategies for clinical trials in type 1 diabetesMario R Ehlers
Biomarkers in Medicine|May 19, 2010
Pacific biomarkers, incMario R Ehlers
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|July 31, 2015
Immune interventions to preserve β cell function in type 1 diabetesMario R Ehlers
Biological Chemistry|May 24, 2014
Immune-modulating effects of alpha-1 antitrypsinMario R Ehlers
Science Immunology|February 13, 2018
Who let the dogs out? The ever-present threat of autoreactive T cellsMario R Ehlers
Current Opinion in Endocrinology, Diabetes, and Obesity|July 2, 2014
Targeted immune interventions for type 1 diabetes: not as easy as it looks!Mark R Rigby, Mario R Ehlers
The Review of Diabetic Studies : RDS|June 28, 2013
Immune-directed therapy for type 1 diabetes at the clinical level: the Immune Tolerance Network (ITN) experienceMario R Ehlers, Gerald T Nepom
Current Diabetes Reports|September 16, 2015
Targeting memory T cells in type 1 diabetesMario R Ehlers, Mark R Rigby
Clinical and Experimental Pharmacology & Physiology|January 29, 2013
Antifibrotic peptide N-acetyl-Ser-Asp-Lys-Pro (Ac-SDKP): opportunities for angiotensin-converting enzyme inhibitor designRoss G Douglas, Mario R Ehlers, Edward D Sturrock
Disease Models & Mechanisms|May 6, 2014
Restoring the balance: immunotherapeutic combinations for autoimmune diseaseDawn E Smilek, Mario R Ehlers, Gerald T Nepom
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Journal of Autoimmunity|April 13, 2016
Strategies for clinical trials in type 1 diabetesMario R Ehlers
Biomarkers in Medicine|May 19, 2010
Pacific biomarkers, incMario R Ehlers
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|July 31, 2015
Immune interventions to preserve β cell function in type 1 diabetesMario R Ehlers
Biological Chemistry|May 24, 2014
Immune-modulating effects of alpha-1 antitrypsinMario R Ehlers
Science Immunology|February 13, 2018
Who let the dogs out? The ever-present threat of autoreactive T cellsMario R Ehlers
Current Opinion in Endocrinology, Diabetes, and Obesity|July 2, 2014
Targeted immune interventions for type 1 diabetes: not as easy as it looks!Mark R Rigby, Mario R Ehlers
The Review of Diabetic Studies : RDS|June 28, 2013
Immune-directed therapy for type 1 diabetes at the clinical level: the Immune Tolerance Network (ITN) experienceMario R Ehlers, Gerald T Nepom
Current Diabetes Reports|September 16, 2015
Targeting memory T cells in type 1 diabetesMario R Ehlers, Mark R Rigby
Clinical and Experimental Pharmacology & Physiology|January 29, 2013
Antifibrotic peptide N-acetyl-Ser-Asp-Lys-Pro (Ac-SDKP): opportunities for angiotensin-converting enzyme inhibitor designRoss G Douglas, Mario R Ehlers, Edward D Sturrock
Disease Models & Mechanisms|May 6, 2014
Restoring the balance: immunotherapeutic combinations for autoimmune diseaseDawn E Smilek, Mario R Ehlers, Gerald T Nepom
Pageof 3